Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Patrys Limited ( (AU:PAB) ) has issued an announcement.
Patrys Limited has announced the quotation of 308,362,535 ordinary fully paid securities on the Australian Securities Exchange (ASX) under the code PAB, effective June 18, 2025. This move is part of previously announced transactions and is expected to enhance the company’s financial flexibility and market presence, potentially impacting its growth strategy and stakeholder value.
More about Patrys Limited
Patrys Limited operates in the biotechnology industry, focusing on the development of novel antibody therapies for cancer treatment. The company is committed to advancing its proprietary Deoxymab platform, which targets DNA damage repair pathways in cancer cells, offering potential therapeutic benefits.
Technical Sentiment Signal: Strong Sell
Current Market Cap: A$3.09M
See more insights into PAB stock on TipRanks’ Stock Analysis page.